(Q33805314)

English

Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

light coagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

diabetic retinopathy

1 reference

based on heuristic

inferred from title

proliferative diabetic retinopathy

1 reference

based on heuristic

inferred from title

Ursula Schmidt-Erfurth

5

object named as

Ursula Schmidt-Erfurth

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

object named as

Matthias Bolz

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Gerald Schmidinger

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Noemi Maar

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Christoph Scholda

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Acta Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

76-81

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01622.X

21 January 2018

Identifiers

10.1111/J.1755-3768.2009.01622.X

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33805314&oldid=1793154449"